Scientists are studying inositols potential to improve insulin sensitivity and treat metabolic diseases such as obesity and type 2 diabetes
Real Results : Since starting my medication, Ive been extra careful about prevention because I know being sick is more complicated now
We typically suggest a slow, gradual reduction of these substances
It is also FDA approved for cardiovascular risk reduction (to lower the risk of heart attack, stroke, and cardiovascular death) in people with both Type 2 diabetes and heart disease
While the research is still emerging and experts still have more work to do the findings are promising for women in the menopause transition who not only want to lose weight, but who also want to set themselves up for a healthier lifestyle in the long run.
Zepbound (tirzepatide) is an FDA-approved dual GIP/GLP-1 receptor agonist indicated for chronic weight management in adults with obesity or overweight with weight-related comorbidities